Of note, CBX2 was found to be overexpressed in human breast tumors compared to normal tissues, and the expression of CBX2 was inversely correlated with the patient’s prognosis, suggesting that high levels of CBX2 are associated with a worse prognosis and could serve as an important prognostic biomarker for patients with breast cancer (BC). Here, CBX2 is linked to breast carcinoma.